The findings of the K-M analysis showed that patients with high HMGN1 expression levels in ACC (p<0.001), ESCA (p=0.031), CESC (p=0.028), KICH (p=0.016), KIRC (p=0.009), LIHC (p<0.001), PCPG (p=0.027), PRAD (p= 0.002), and UVM (p=0.049) patients presented a worse prognosis (Fig. 5E). This evidence concerns the gene HMGN1 and adrenal cortex carcinoma.